1. Immunology/Inflammation
  2. NO Synthase
  3. Lipoamide

Lipoamide  (Synonyms: (±)-α-Lipoamide; DL-Lipoamide; DL-6,8-Thioctamide)

Cat. No.: HY-B1142 Purity: 99.40%
SDS COA Handling Instructions

Lipoamide ((±)-α-Lipoamide) is a monocarboxylic acid derivative of a neutral amide, formed by the condensation of the carboxyl group of lipoic acid and ammonia. Lipoamide protects against oxidative stress-mediated neuronal cell damage and also acts as a coenzyme to transfer acetyl groups and hydrogen during pyruvate deacylation. Lipoamide also stimulates mitochondrial biogenesis in adipocytes through the endothelial NO synthase-cGMP-protein kinase G signaling pathway.

For research use only. We do not sell to patients.

Lipoamide Chemical Structure

Lipoamide Chemical Structure

CAS No. : 940-69-2

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
100 mg USD 30 In-stock
500 mg USD 60 In-stock
1 g   Get quote  
5 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 6 publication(s) in Google Scholar

Top Publications Citing Use of Products

View All NO Synthase Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Lipoamide ((±)-α-Lipoamide) is a monocarboxylic acid derivative of a neutral amide, formed by the condensation of the carboxyl group of lipoic acid and ammonia. Lipoamide protects against oxidative stress-mediated neuronal cell damage and also acts as a coenzyme to transfer acetyl groups and hydrogen during pyruvate deacylation. Lipoamide also stimulates mitochondrial biogenesis in adipocytes through the endothelial NO synthase-cGMP-protein kinase G signaling pathway[1][2].

IC50 & Target

Human Endogenous Metabolite

 

In Vitro

Lipoamide (10-100 μM; 24 h) can reduce H2O2 or 6-OHDA-induced PC12 cell damage and apoptosis, reduce LDH leakage and Caspase-3 activity[2].
Lipoamide (100 μM; 8 h) also upregulates the expression of Nrf2 in PC12 cells, promotes the nuclear translocation of Nrf2 and downstream gene expression, such as inducing the transcription of Nrf2-regulated antioxidant genes[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[2]

Cell Line: PC12 cells
Concentration: 10, 50, 100 μM
Incubation Time: 24 h; while cells were cultured with H2O2 or 6-OHDA for 5 h.
Result: Effectively and dose-dependently rescued PC12 cells from cell injury caused by H2O2 or 6-OHDA.
Significantly restored H2O2 or 6-OHDA-induced LDH leakage.
Dose-dependently improved H2O2- or 6-OHDA-induced cell viability decrease.

Western Blot Analysis[2]

Cell Line: PC12 cells
Concentration: 10, 50, 100 μM
Incubation Time: 2, 4, 8 h; while cells were cultured with H2O2 or 6-OHDA for 5 h.
Result: Improved the expression of nuclear Nrf2 remarkably, and the peak occurred at 4 h.
Molecular Weight

205.34

Formula

C8H15NOS2

CAS No.
Appearance

Solid

Color

Light yellow to yellow

SMILES

O=C(N)CCCCC1SSCC1

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage
Powder -20°C 3 years
4°C 2 years

*The compound is unstable in solutions, freshly prepared is recommended.

Solvent & Solubility
In Vitro: 

DMSO : ≥ 50 mg/mL (243.50 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

H2O : 0.67 mg/mL (3.26 mM; Need ultrasonic)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 4.8700 mL 24.3499 mL 48.6997 mL
5 mM 0.9740 mL 4.8700 mL 9.7399 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.38 mg/mL (11.59 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.38 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (23.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.08 mg/mL (10.13 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*The compound is unstable in solutions, freshly prepared is recommended.

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation

Purity: 99.40%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
H2O / DMSO 1 mM 4.8700 mL 24.3499 mL 48.6997 mL 121.7493 mL
DMSO 5 mM 0.9740 mL 4.8700 mL 9.7399 mL 24.3499 mL
10 mM 0.4870 mL 2.4350 mL 4.8700 mL 12.1749 mL
15 mM 0.3247 mL 1.6233 mL 3.2466 mL 8.1166 mL
20 mM 0.2435 mL 1.2175 mL 2.4350 mL 6.0875 mL
25 mM 0.1948 mL 0.9740 mL 1.9480 mL 4.8700 mL
30 mM 0.1623 mL 0.8117 mL 1.6233 mL 4.0583 mL
40 mM 0.1217 mL 0.6087 mL 1.2175 mL 3.0437 mL
50 mM 0.0974 mL 0.4870 mL 0.9740 mL 2.4350 mL
60 mM 0.0812 mL 0.4058 mL 0.8117 mL 2.0292 mL
80 mM 0.0609 mL 0.3044 mL 0.6087 mL 1.5219 mL
100 mM 0.0487 mL 0.2435 mL 0.4870 mL 1.2175 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Lipoamide
Cat. No.:
HY-B1142
Quantity:
MCE Japan Authorized Agent: